Multicenter Retrospective Study of Cefmetazole and Flomoxef for Treatment of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Bacteremia

Yasufumi Matsumura, Masaki Yamamoto, Miki Nagao, +9

Antimicrobial Agents and Chemotherapy

Antimicrobial ChemotherapyAntibiotic ResistanceLogistic AnalysisAntimicrobial StewardshipMulticenter Retrospective Study +14

CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant <i>Escherichia coli</i> of the <i>H</i> 30 subclonal group within ST131 drive a Japanese regional ESBL epidemic

Yasufumi Matsumura, James R. Johnson, Masaki Yamamoto, +25

Journal of Antimicrobial Chemotherapy

Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes

Yasufumi Matsumura, Yuichiro Shindo, Yoshitsugu Iinuma, +8

BMC Infectious Diseases

Rapid Identification of Different Escherichia coli Sequence Type 131 Clades

Yasufumi Matsumura, Johann Pitout, Gisele Peirano, +9

Antimicrobial Agents and Chemotherapy

Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum- -lactamase-producing Escherichia coli in Japan

Yasufumi Matsumura, Masaki Yamamoto, Miki Nagao, +5

Journal of Antimicrobial Chemotherapy

Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012–2014

Satoshi Nakano, Takao Fujisawa, Yutaka Ito, +10

Vaccine

Molecular EpidemiologyKlebsiella PneumoniaeIpd IsolatesBacterial PathogensIpd Patients +16

Quantitative real-time PCR and the (1 → 3)-β-d-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization

Yasufumi Matsumura, Yutaka Ito, Yoshitsugu Iinuma, +5

Clinical Microbiology and Infection

Medical MicrobiologyPneumocystis Jirovecii PneumoniaMedicineQuantitative Real-time PcrInfectious Respiratory Disease +6

Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia

Miki Nagao, Yoshitsugu Iinuma, Takashi Saito, +6

Clinical Microbiology and Infection

Better ManagementHealthcare-associated InfectionPatient SafetyClinical InfectionInfectious Disease Physicians +4

Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation

Karin Kato, Miki Nagao, Kentaro Miyamoto, +7

Transplantation Direct

SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression

Rina Hashimoto, Junya Takahashi, Keisuke Shirakura, +29

Science Advances